Page last updated: 2024-10-28

hexamethonium and Cholecystitis

hexamethonium has been researched along with Cholecystitis in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Cholecystitis: Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
JivegÄrd, L1
Thornell, E1
Svanvik, J1

Other Studies

1 other study available for hexamethonium and Cholecystitis

ArticleYear
Fluid secretion by gallbladder mucosa in experimental cholecystitis is influenced by intramural nerves.
    Digestive diseases and sciences, 1987, Volume: 32, Issue:12

    Topics: Animals; Atropine; Autonomic Nervous System; Body Fluids; Cats; Cholecystitis; Dinoprostone; Female;

1987